ATOSSA THERAPEUTICS, INC. Interest Expense
ATOSSA THERAPEUTICS, INC. (ATOS) reported Interest Expense of $1.78 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-13.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2015-05-13
- ATOSSA THERAPEUTICS, INC. interest expense for the quarter ending 2015-03-31 was $1.78K, a 138.18% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. interest expense for the quarter ending 2014-12-31 was $13.43K.
- ATOSSA THERAPEUTICS, INC. interest expense for the quarter ending 2014-09-30 was $151.00, a 15000.00% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. interest expense for the quarter ending 2014-06-30 was $1.44K, a 309.94% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. interest expense for fiscal 2014 was $15.77K, a 4280.28% increase from fiscal 2013.
- ATOSSA THERAPEUTICS, INC. interest expense for fiscal 2013 was $360.00, a 97.01% decline from fiscal 2012.
- ATOSSA THERAPEUTICS, INC. interest expense for fiscal 2012 was $12.04K, a 33.08% decline from fiscal 2011.
- ATOSSA THERAPEUTICS, INC. interest expense for fiscal 2011 was $17.99K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 41 month | Interest Expense 44 month | Interest Expense 47 month | Interest Expense 50 month | Interest Expense 53 month | Interest Expense 56 month | Interest Expense 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $1.78K 10-Q · filed 2015-05-13 | $15.21K derived: sum of 2 quarters · filed 2015-05-13 | $15.36K derived: sum of 3 quarters · filed 2015-05-13 | $16.80K derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-12-31 | $13.43K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $13.58K derived: sum of 2 quarters · filed 2015-03-30 | $15.02K derived: sum of 3 quarters · filed 2015-03-30 | $15.77K 10-K · filed 2015-03-30 | |||||||
| 2014-09-30 | $151.00 10-Q · filed 2014-11-12 | $1.59K derived: sum of 2 quarters · filed 2014-11-12 | $2.34K 10-Q · filed 2014-11-12 | $2.34K derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-06-30 | $1.44K 10-Q · filed 2014-08-12 | $2.19K 10-Q · filed 2014-08-12 | $2.19K derived: sum of 3 quarters · filed 2015-05-13 | $2.19K derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-03-31 | $749.00 10-Q · filed 2015-05-13 | $749.00 derived: sum of 2 quarters · filed 2015-05-13 | $750.00 derived: sum of 3 quarters · filed 2015-05-13 | $1.10K derived: sum of 4 quarters · filed 2015-05-13 | $40.28K 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $1.00 derived: sum of 2 quarters · filed 2015-03-30 | $353.00 derived: sum of 3 quarters · filed 2015-03-30 | $360.00 10-K · filed 2015-03-30 | $39.53K 10-K · filed 2014-03-27 | ||||||
| 2013-09-30 | $1.00 10-Q · filed 2014-11-12 | $353.00 derived: sum of 2 quarters · filed 2014-11-12 | $360.00 10-Q · filed 2014-11-12 | $584.00 derived: sum of 4 quarters · filed 2014-11-12 | $39.53K 10-Q · filed 2013-11-12 | ||||||
| 2013-06-30 | $352.00 10-Q · filed 2014-08-12 | $359.00 10-Q · filed 2014-08-12 | $583.00 derived: sum of 3 quarters · filed 2014-08-12 | $8.34K derived: sum of 4 quarters · filed 2014-08-12 | $39.53K 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | $7.00 10-Q · filed 2014-05-14 | $231.00 derived: sum of 2 quarters · filed 2014-05-14 | $7.99K derived: sum of 3 quarters · filed 2014-05-14 | $10.43K derived: sum of 4 quarters · filed 2014-05-14 | $39.18K 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | $224.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $7.98K derived: sum of 2 quarters · filed 2014-03-27 | $10.43K derived: sum of 3 quarters · filed 2014-03-27 | $12.04K 10-K · filed 2014-03-27 | $39.17K 10-K · filed 2013-03-28 | ||||||
| 2012-09-30 | $7.76K 10-Q · filed 2013-11-12 | $10.20K derived: sum of 2 quarters · filed 2013-11-12 | $11.82K 10-Q · filed 2013-11-12 | $21.42K derived: sum of 4 quarters · filed 2013-11-12 | $38.95K 10-Q/A · filed 2013-01-22 | ||||||
| 2012-06-30 | $2.45K 10-Q · filed 2013-08-14 | $4.06K 10-Q · filed 2013-08-14 | $13.66K derived: sum of 3 quarters · filed 2013-08-14 | $14.42K derived: sum of 4 quarters · filed 2013-08-14 | |||||||
| 2012-03-31 | $1.61K 10-Q · filed 2013-05-15 | $11.22K derived: sum of 2 quarters · filed 2013-05-15 | $11.97K derived: sum of 3 quarters · filed 2013-05-15 | ||||||||
| 2011-12-31 | $9.60K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | $10.36K derived: sum of 2 quarters · filed 2013-03-28 | $17.99K 10-K · filed 2013-03-28 | ||||||||
| 2011-09-30 | $758.00 10-Q/A · filed 2013-01-22 | $8.39K 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |